M&A

Plastiflex buys Italian medical-tubing maker Sidam to expand fluid management

What's the deal? Plastiflex GroupDealroom has a profile for this one. Try Dealroom → has acquired Sidam S.r.l.Dealroom has a profile for this one. Try Dealroom → from Mindful Capital PartnersDealroom has a profile for this one. Try Dealroom →, folding the Italian medical-device maker into its healthcare portfolio. Sidam designs single-use tubing systems for preparing, handling, and delivering complex substances used in radiology, radiopharma, stem cell therapy, and oncology. Terms were not disclosed.

Who's who? PlastiflexDealroom has a profile for this one. Try Dealroom →, founded in 1953, is a world leader in tubing systems and components for healthcare and other sectors, employing more than 1,300 people. Sidam, founded in 1991 and based in Mirandola, Italy, is a contract developer and manufacturer serving global OEM customers, with more than 200 staff.

What's the endgame? The deal strengthens Plastiflex's fluid management segment and pushes it into fast-growing therapeutic areas. It also adds a production platform in the Mirandola area and extends the combined firm's healthcare footprint across North America, EMEA, and Asia.

What changes? Sidam's leadership, led by chief executive officer Annalisa Azzolina, joins Plastiflex's fluid management team, and its production and research sites stay open. Sidam customers gain access to additional manufacturing capacity across Asia and North America.

Piet Gruwez, chief executive officer of Plastiflex, called the transaction "another step in our healthcare focussed growth strategy." Azzolina said the two companies would offer customers "an even stronger and more comprehensive product portfolio."

The signal: The acquisition reflects continued consolidation among contract manufacturers of specialised medical devices, as buyers add capabilities in high-growth areas like radiopharma and cell therapy to build broader, globally distributed platforms.

Read more: plastiflex.com

Image credit: Generated with Gemini

More top stories